Suppr超能文献

三甲丙醇增强了MgNa2EDTA对家兔体内的负性肌力作用。

Trimepranol increases a negative inotropic effect of MgNa2EDTA in rabbits in vivo.

作者信息

Gersl V, Pokorná P, Stĕpánková J

出版信息

Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove. 1990;33(2):191-8.

PMID:1983045
Abstract

The effect of a pre-treatment with the chelator MgNa2EDTA (0.5 mg.kg-1 i.v.) on the influencing of cardiac contractility by Trimepranol (0.3 mg.kg-1 i.v.) was studied in rabbits in vivo under pentobarbital anaesthesia in the conditions of the spontaneous and paced heart rates and compared with the effects of the administration of the chelator MgNa2EDTA (0.5 mg.kg-1 i.v.) alone. The administration of the chelator alone induced especially commencing with the end of the first hour of observation, a progressive decrease in the left ventricular dP/dtmax. both in the paced heart (max. 67.0 % in the 170th min) and in the nonpaced heart conditions (max. 60.9 % in the 180th min). The administration of Trimepranol (120 min after the pre-treatment with the chelator) resulted in a pronounced increase in a negative inotropic effect (max. 43.1% in the paced and 35.3 % in the non-paced heart, always in the 130th min, i.e., 10 min after the administration of the beta-blocker), which was in most intervals significantly different from the values of dP/dtmax. after the administration of the chelator alone. A significant increase in the negative inotropic effect was manifested also by deaths of a number of experimental animals before the end of observation. On the basis of the results obtained, it is possible to assume that the combination of the administration of MgNa2EDTA with beta-blockers may especially result in an increase in the cardiodepressive action and in an occurrence of adverse effects on the hemodynamics of the organism.

摘要

在戊巴比妥麻醉下,于家兔体内,在自发心率和起搏心率条件下,研究了螯合剂乙二胺四乙酸镁二钠(0.5毫克/千克静脉注射)预处理对曲美托嗪(0.3毫克/千克静脉注射)影响心脏收缩力的作用,并与单独给予螯合剂乙二胺四乙酸镁二钠(0.5毫克/千克静脉注射)的效果进行比较。单独给予螯合剂,特别是从观察开始的第一小时末起,无论是在起搏心脏(在第170分钟时最大降低67.0%)还是在非起搏心脏条件下(在第180分钟时最大降低60.9%),左心室dP/dtmax均出现逐渐下降。给予曲美托嗪(在螯合剂预处理120分钟后)导致负性肌力作用显著增强(起搏心脏中最大增强43.1%,非起搏心脏中最大增强35.3%,均在第130分钟,即β受体阻滞剂给药后10分钟),在大多数时间段,该值与单独给予螯合剂后的dP/dtmax值有显著差异。许多实验动物在观察结束前死亡也表明负性肌力作用显著增强。根据所得结果,可以假设乙二胺四乙酸镁二钠与β受体阻滞剂联合使用可能尤其会导致心脏抑制作用增强以及对机体血液动力学产生不良反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验